Search research articles
Contact Us
Filters
Showing results (21-30 of 353) with videos related to
Page
of 36
Sort By:
Oncology (Williston Park, N.Y.)
|
May 19, 2017
Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New Directions
Patrick M Reagan, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2023
Classic Hodgkin Lymphoma in Adolescents and Young Adults
Kara M Kelly, Jonathan W Friedberg
Current Oncology Reports
|
August 19, 2008
Beyond rituximab: the future of monoclonal antibodies in B-cell non-Hodgkin lymphoma
Manzurul A Sikder, Jonathan W Friedberg
The Oncologist
|
April 4, 2009
Salvage therapy in Hodgkin's lymphoma
Jason H Mendler, Jonathan W Friedberg
Current Hematologic Malignancy Reports
|
May 4, 2010
Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?
David W Dougherty, Jonathan W Friedberg
Seminars in Hematology
|
April 3, 2008
Monoclonal antibodies in lymphoma: the first decade
Brian K Link, Jonathan W Friedberg
Future Oncology (London, England)
|
May 13, 2015
Advancing radioimmunotherapy and its future role in non-Hodgkin lymphoma
Patrick M Reagan, Jonathan W Friedberg
Current Treatment Options in Oncology
|
June 3, 2015
Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma
Patrick M Reagan, Jonathan W Friedberg
Hematology. American Society of Hematology. Education Program
|
December 17, 2008
Burkitt lymphoma in adults
Archibald S Perkins, Jonathan W Friedberg
Health Services Research
|
June 4, 2016
Evaluating the Impact of Parent-Reported Medical Home Status on Children's Health Care Utilization, Expenditures, and Quality: A Difference-in-Differences Analysis with Causal Inference Methods
Bing Han, Hao Yu, Mark W Friedberg
Page
of 36
Search research articles
Search
Showing results (21-30 of 353) with videos related to
Sort By:
Page
of 36
Oncology (Williston Park, N.Y.)
|
May 19, 2017
Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New Directions
Patrick M Reagan, Jonathan W Friedberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2023
Classic Hodgkin Lymphoma in Adolescents and Young Adults
Kara M Kelly, Jonathan W Friedberg
Current Oncology Reports
|
August 19, 2008
Beyond rituximab: the future of monoclonal antibodies in B-cell non-Hodgkin lymphoma
Manzurul A Sikder, Jonathan W Friedberg
The Oncologist
|
April 4, 2009
Salvage therapy in Hodgkin's lymphoma
Jason H Mendler, Jonathan W Friedberg
Current Hematologic Malignancy Reports
|
May 4, 2010
Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?
David W Dougherty, Jonathan W Friedberg
Seminars in Hematology
|
April 3, 2008
Monoclonal antibodies in lymphoma: the first decade
Brian K Link, Jonathan W Friedberg
Future Oncology (London, England)
|
May 13, 2015
Advancing radioimmunotherapy and its future role in non-Hodgkin lymphoma
Patrick M Reagan, Jonathan W Friedberg
Current Treatment Options in Oncology
|
June 3, 2015
Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma
Patrick M Reagan, Jonathan W Friedberg
Hematology. American Society of Hematology. Education Program
|
December 17, 2008
Burkitt lymphoma in adults
Archibald S Perkins, Jonathan W Friedberg
Health Services Research
|
June 4, 2016
Evaluating the Impact of Parent-Reported Medical Home Status on Children's Health Care Utilization, Expenditures, and Quality: A Difference-in-Differences Analysis with Causal Inference Methods
Bing Han, Hao Yu, Mark W Friedberg
Page
of 36